Can Farxiga (dapagliflozin) or Aldactone (spironolactone) cause a dry cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Farxiga or Aldactone Cause Dry Cough?

Neither Farxiga (dapagliflozin) nor Aldactone (spironolactone) are known to cause dry cough as a side effect. These medications work through entirely different mechanisms than the drug class most commonly associated with chronic dry cough—ACE inhibitors.

Why This Matters: Understanding Drug-Induced Cough

ACE Inhibitors Are the Primary Culprit

  • Dry cough is a well-established class effect of ACE inhibitors (such as enalapril, captopril, ramipril, and lisinopril), occurring in 5-35% of patients treated with these agents 1
  • The cough is typically dry, nonproductive, associated with a tickling or scratching sensation in the throat, and often worse at night 1, 2
  • ACE inhibitor-induced cough can begin within hours of the first dose or be delayed for weeks to months after starting therapy 1
  • The mechanism involves accumulation of bradykinin, substance P, and prostaglandins due to inhibition of their degradation 1, 3

Farxiga and Aldactone Have Different Mechanisms

  • Farxiga (dapagliflozin) is an SGLT2 inhibitor that works by blocking glucose reabsorption in the kidneys—it has no effect on the bradykinin-prostaglandin pathway that causes ACE inhibitor cough
  • Aldactone (spironolactone) is a potassium-sparing diuretic and aldosterone antagonist that also does not interact with the cough reflex pathways

If You're Experiencing Dry Cough

Look for the Real Cause

  • Review all medications for ACE inhibitors (drugs ending in "-pril" such as lisinopril, enalapril, ramipril, captopril) 1, 4
  • ACE inhibitors are the most likely pharmaceutical cause of chronic dry cough, with symptoms beginning after several months of treatment in many cases 4
  • Beta-blockers can rarely cause or exacerbate cough, though this is much less common than with ACE inhibitors 4

Management Strategy

  • If taking an ACE inhibitor, discontinue it under medical supervision regardless of when the cough started relative to beginning the medication 1
  • Switching to an angiotensin receptor blocker (ARB) such as candesartan or losartan is the preferred alternative, as ARBs do not cause cough even in patients with prior ACE inhibitor-induced cough 4
  • Cough typically resolves within 1-4 weeks after stopping the ACE inhibitor, though it may take up to 3 months in some patients 1, 3

Other Common Causes to Consider

  • Laryngopharyngeal reflux (silent reflux) is a frequent cause of chronic cough, especially in older, overweight patients with diabetes 4
  • Consider a 4-week trial of proton pump inhibitor therapy if reflux is suspected 4
  • Pulmonary edema from congestive heart failure can occasionally present with cough as the sole symptom 1

Critical Pitfall to Avoid

Do not assume the timing rules out ACE inhibitors as the cause. The cough can develop months or even a year after starting therapy, not just in the first few weeks 3. Many patients and physicians fail to recognize this delayed presentation and attribute the cough to other causes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Characterization of cough associated with angiotensin-converting enzyme inhibitors.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1991

Guideline

Diagnosis and Treatment of Chronic Hoarseness, Cough, and Pain when Speaking

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.